India, Sept. 16 -- Molbio Diagnostics, a Goa-based point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies, and UE LifeSciences, a Philadelphia-based innovator engaged in the business of developing and manufacturing health technology solutions, with a primary focus on enabling early cancer detection technologies, have announced an exclusive collaboration, seeking to make early breast cancer detection accessible to millions of women in over 50 countries across the developing world.
Through this collaboration, Molbio will bring UE LifeSciences'iBreastExam(R)-a radiation-free, painless, and FDA-cleared screening device across India, Africa, the Middle East, CIS countr...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.